港股異動 | 滔搏(6110.HK)漲4%再創新高 市值超850億港元
格隆匯1月28日丨滔搏(6110.HK)逆勢拉漲4%,報13.78港元再創新高價,總市值超850億港元。大摩預期未來幾年南下資金會持續流入體育用品板塊,並非短期炒作,故料相關股份估值仍有望提升。將滔搏由13.1港元升至15.3港元,維持增持評級。考慮到滔搏2021下半財年至2022上半財年將實現強勁的銷售和盈利提升。據格隆匯APP顯示,近日南下資金明顯增持滔搏,雖總體比例不大,但相比之前確上升明顯,最新持股比列為0.63%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.